hsa-miR-200c

ncRNA information

ncRNA name

hsa-miR-200c

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ZEB2

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

50

Male patients

28

Female patients

22

Age range and number

Not available

Research information

PMID

Description

Upregulation of miR-200c or downregulation of ZEB2 enhanced the sensitivity of SGC7901/DDP cells to DDP.

Tissue resource

gastric cancer tissues and paired normal adjacent tissues

human gastric cancer cell lines SGC7901

human gastric cancer cisplatin-resistant cell lines SGC7901/DDP

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

the First Affiliated Hospital of Henan University of Science and Technology

the Cell Bank of the Chinese Academy of Sciences

the KeyGen Biotech Co., Ltd.

Country

China

Continent

Asia